Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...
Saved in:
| Superior document: | Frontiers Research Topics |
|---|---|
| : | |
| Year of Publication: | 2018 |
| Language: | English |
| Series: | Frontiers Research Topics
|
| Physical Description: | 1 electronic resource (385 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
System Under Maintenance
Our Library Management System is currently under maintenance.
Holdings and item availability information is currently unavailable. Please accept our apologies for any inconvenience this may cause and contact us for further assistance: